NetworkยทVenture Capital
๐ NEW YORK, NY
SEC CRD #801-110367
Welcome to Formula Growth Limited EN FR USA MONTREAL 1010 Sherbrooke St. W Suite 2300 Montreal, QC, H3A 2R7 Canada NEW YORK 1 Rockefeller Plaza Suite 1421 New York, NY, 10020 USA --> --> Manage Cookie Consent Your privacy is important to us. We use cookies to personalize your content and make your digital experience better. Certain cookies may be collected with your consent. Functional Functional Always active The technical storage or access is strictly necessary to allow you to access all site features and browse our website in an optimal manner. Preferences Preferences The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user. Statistics Statistics The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. Marketing Marketing The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage options Manage services Manage {vendor_count} vendors Read more about these purposes Accept Deny View preferences Save preferences View preferenc
ARGIRIOS KIRIAZIDIS
CHIEF COMPLIANCE OFFICER, CHIEF OPERATING OFFICER
๐ (917) 265-8286
๐ Sign up for free to view key contact information
Sign up free โThis profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
AUM
$344M
Check Size
$2.3Bโ$2.3B
Location
NEW YORK, NY
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.